Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

09/08/2019 07:01

Aug 9 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.42                1.27             11.26    
                   (+11.9 pct)         (-9.5 pct)       (+8.1 pct)  
  Operating          180 mln             61 mln             2.20    
                  (+193.0 pct)         (-66.0 pct)      (+8.4 pct)  
  Recurring          127 mln             28 mln             1.95    
                  (+347.2 pct)         (-77.8 pct)      (+3.4 pct)  
  Net                103 mln             38 mln             1.42    
                  (+165.8 pct)         (-61.1 pct)      (+0.3 pct)  
  EPS               7.22 yen            2.72 yen         99.00 yen  
  EPS Diluted       7.21 yen            2.72 yen                    
  Ann Div                               35.00 yen        30.00 yen  
  -Q2 div                               10.00 yen        10.00 yen  
  -Q4 div                               25.00 yen        20.00 yen  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T